AttnKare

AttnKare-D, a diagnostic software for ADHD children, utilizes Virtual Reality (VR) and Artificial Intelligence (AI) technologies.

Active child engagement in VR missions and systematic behavior data collection enables precise quantification of ADHD symptom severity through AI analysis.

The analysis results are presented in a clear and concise report format for easy understanding for medical professionals and parents.

AttnKare-T is specifically developed to alleviate symptoms of ADHD by utilizing tablet based racing games and personalized cognitive-behavioral therapy (CBT) missions.

CBT missions are developed in collaboration with medical professionals and psychologists, aiming to equip children with skills that are applicable to their daily lives.

Being tablet-based, it enables treatment to be conducted at any time and from any location.

According to estimates by European institutions, it is now believed that at least 3.3 million school-aged children in the European Union have ADHD.

AttnKare primarily targets hospitals, pharmacies, and mental health centers.

AttnKare-D, as a non-prescription medical device for one-time use, incurs a diagnostic testing fee, while AttnKare-T operates on a monthly subscription model, requiring a recurring fee.

The present prevalence of ADHD and the growing interest in this condition indicate a significant demand for our products.